Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308207441> ?p ?o ?g. }
- W4308207441 endingPage "4675" @default.
- W4308207441 startingPage "4675" @default.
- W4308207441 abstract "The antineoplastic effects of docosahexaenoic acid-containing phosphatidylcholine (DHA-PC) and eicosapentaenoic acid-containing phosphatidylcholine (EPA-PC) were explored, and their underlying mechanisms in the human lung carcinoma 95D cells (95D cells) were investigated. After treatment of 95D cells with DHA-PC or EPA-PC, cell biological behaviors such as growth, adhesion, migration, and invasion were studied. Immunofluorescence and western blotting were carried out to assess underlying molecular mechanisms. Results showed that 95D cells proliferation and adherence in the DHA-PC or EPA-PC group were drastically inhibited than the control group. DHA-PC and EPA-PC suppressed the migration and invasion of 95D cells by disrupting intracellular F-actin, which drives cell movement. The protein expression of PPARγ was induced versus the control group. Furthermore, critical factors related to invasion, including matrix metallopeptidase 9 (MMP9), heparanase (Hpa), and vascular endothelial growth factor (VEGF), were drastically downregulated through the PPARγ/NF-κB signaling pathway. C-X-C chemokine receptor type 4 (CXCR4) and cofilin were significantly suppressed via DHA-PC and EPA-PC through the PPARγ/phosphatase and tensin homolog (PTEN)/serine-threonine protein kinase (AKT) signaling pathway. DHA-PC and EPA-PC reversed the PPARγ antagonist GW9662-induced reduction of 95D cells in migration and invasion capacity, suggesting that PPARγ was directly involved in the anti-metastasis efficacy of DHA-PC and EPA-PC. In conclusion, DHA-PC and EPA-PC have great potential for cancer therapy, and the antineoplastic effects involve the activation of PPARγ. EPA-PC showed more pronounced antineoplastic effects than DHA-PC, possibly due to the more robust activation of PPARγ by EPA-PC." @default.
- W4308207441 created "2022-11-09" @default.
- W4308207441 creator A5019126433 @default.
- W4308207441 creator A5020503386 @default.
- W4308207441 creator A5030689354 @default.
- W4308207441 creator A5042491947 @default.
- W4308207441 creator A5054464310 @default.
- W4308207441 creator A5057791496 @default.
- W4308207441 creator A5067368540 @default.
- W4308207441 creator A5081759967 @default.
- W4308207441 creator A5089444109 @default.
- W4308207441 date "2022-11-04" @default.
- W4308207441 modified "2023-10-14" @default.
- W4308207441 title "DHA- and EPA-Enriched Phosphatidylcholine Suppress Human Lung Carcinoma 95D Cells Metastasis via Activating the Peroxisome Proliferator-Activated Receptor γ" @default.
- W4308207441 cites W1181104234 @default.
- W4308207441 cites W1554536030 @default.
- W4308207441 cites W1975016039 @default.
- W4308207441 cites W2012538473 @default.
- W4308207441 cites W2024923017 @default.
- W4308207441 cites W2033982986 @default.
- W4308207441 cites W2034239465 @default.
- W4308207441 cites W2050859146 @default.
- W4308207441 cites W2057516761 @default.
- W4308207441 cites W2102681733 @default.
- W4308207441 cites W2104657315 @default.
- W4308207441 cites W2106844732 @default.
- W4308207441 cites W2136644969 @default.
- W4308207441 cites W2138933179 @default.
- W4308207441 cites W2159391562 @default.
- W4308207441 cites W2518749072 @default.
- W4308207441 cites W2552965505 @default.
- W4308207441 cites W2601217965 @default.
- W4308207441 cites W2622601036 @default.
- W4308207441 cites W2747826704 @default.
- W4308207441 cites W2762144498 @default.
- W4308207441 cites W2783060472 @default.
- W4308207441 cites W2795174081 @default.
- W4308207441 cites W2797031474 @default.
- W4308207441 cites W2810867486 @default.
- W4308207441 cites W2830855885 @default.
- W4308207441 cites W2875388802 @default.
- W4308207441 cites W2889646458 @default.
- W4308207441 cites W2889664504 @default.
- W4308207441 cites W2891751260 @default.
- W4308207441 cites W2900314536 @default.
- W4308207441 cites W2966550470 @default.
- W4308207441 cites W2970320198 @default.
- W4308207441 cites W2977373736 @default.
- W4308207441 cites W3007687927 @default.
- W4308207441 cites W3009121232 @default.
- W4308207441 cites W3009836641 @default.
- W4308207441 cites W3015446222 @default.
- W4308207441 cites W3021625038 @default.
- W4308207441 cites W3029332911 @default.
- W4308207441 cites W3034271817 @default.
- W4308207441 cites W3040981768 @default.
- W4308207441 cites W3090808912 @default.
- W4308207441 cites W3091819573 @default.
- W4308207441 cites W3119474450 @default.
- W4308207441 cites W3137110787 @default.
- W4308207441 cites W3147142721 @default.
- W4308207441 cites W3164513367 @default.
- W4308207441 cites W3180434180 @default.
- W4308207441 cites W3209345209 @default.
- W4308207441 cites W4200462403 @default.
- W4308207441 cites W4205765008 @default.
- W4308207441 cites W4281653050 @default.
- W4308207441 cites W4295517272 @default.
- W4308207441 cites W4297236478 @default.
- W4308207441 doi "https://doi.org/10.3390/nu14214675" @default.
- W4308207441 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36364935" @default.
- W4308207441 hasPublicationYear "2022" @default.
- W4308207441 type Work @default.
- W4308207441 citedByCount "1" @default.
- W4308207441 countsByYear W43082074412023 @default.
- W4308207441 crossrefType "journal-article" @default.
- W4308207441 hasAuthorship W4308207441A5019126433 @default.
- W4308207441 hasAuthorship W4308207441A5020503386 @default.
- W4308207441 hasAuthorship W4308207441A5030689354 @default.
- W4308207441 hasAuthorship W4308207441A5042491947 @default.
- W4308207441 hasAuthorship W4308207441A5054464310 @default.
- W4308207441 hasAuthorship W4308207441A5057791496 @default.
- W4308207441 hasAuthorship W4308207441A5067368540 @default.
- W4308207441 hasAuthorship W4308207441A5081759967 @default.
- W4308207441 hasAuthorship W4308207441A5089444109 @default.
- W4308207441 hasBestOaLocation W43082074411 @default.
- W4308207441 hasConcept C170493617 @default.
- W4308207441 hasConcept C185592680 @default.
- W4308207441 hasConcept C187345961 @default.
- W4308207441 hasConcept C2777093181 @default.
- W4308207441 hasConcept C2777609662 @default.
- W4308207441 hasConcept C2779549131 @default.
- W4308207441 hasConcept C502942594 @default.
- W4308207441 hasConcept C55493867 @default.
- W4308207441 hasConcept C62478195 @default.
- W4308207441 hasConcept C86554907 @default.
- W4308207441 hasConcept C86803240 @default.
- W4308207441 hasConcept C95444343 @default.